489 related articles for article (PubMed ID: 21827863)
1. A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers.
Liu Y; Reidler H; Pan J; Milunic D; Qin D; Chen D; Vallejo YR; Yin R
J Pharmacol Toxicol Methods; 2011; 64(3):238-45. PubMed ID: 21827863
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the NIDS® rapid assay with ELISA methods in immunogenicity testing of two biotherapeutics.
Pan J; Small T; Qin D; Li S; Wang L; Chen D; Pauley C; Verch T; Kaplanski C; Bakhtiar R; Vallejo YR; Yin R
J Pharmacol Toxicol Methods; 2011; 63(2):150-9. PubMed ID: 20868758
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
[TBL] [Abstract][Full Text] [Related]
4. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.
Li J; Schantz A; Schwegler M; Shankar G
J Pharm Biomed Anal; 2011 Jan; 54(2):286-94. PubMed ID: 20869832
[TBL] [Abstract][Full Text] [Related]
5. Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.
Mikulskis A; Yeung D; Subramanyam M; Amaravadi L
J Immunol Methods; 2011 Feb; 365(1-2):38-49. PubMed ID: 21130095
[TBL] [Abstract][Full Text] [Related]
6. A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum.
Ehlinger C; Spear N; Doddareddy R; Shankar G; Schantz A
J Immunol Methods; 2019 Nov; 474():112669. PubMed ID: 31614128
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of PEGylated interferon detection by anti-polyethylene glycol (PEG) antibodies depends on PEG length.
Cheng TC; Chuang KH; Chen M; Wang HE; Tzou SC; Su YC; Chuang CH; Kao CH; Chen BM; Chang LS; Roffler SR; Cheng TL
Bioconjug Chem; 2013 Aug; 24(8):1408-13. PubMed ID: 23837865
[TBL] [Abstract][Full Text] [Related]
8. Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins.
Saifer MG; Williams LD; Sobczyk MA; Michaels SJ; Sherman MR
Mol Immunol; 2014 Feb; 57(2):236-46. PubMed ID: 24200843
[TBL] [Abstract][Full Text] [Related]
9. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies.
Wang SJ; Wu ST; Gokemeijer J; Fura A; Krishna M; Morin P; Chen G; Price K; Wang-Iverson D; Olah T; Weiner R; Tymiak A; Jemal M
Anal Bioanal Chem; 2012 Jan; 402(3):1229-39. PubMed ID: 22130720
[TBL] [Abstract][Full Text] [Related]
10. Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodies.
Stubenrauch K; Mackeben K; Vogel R; Heinrich J
Anal Biochem; 2012 Nov; 430(2):193-9. PubMed ID: 22935295
[TBL] [Abstract][Full Text] [Related]
11. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
Qiu ZJ; Ying Y; Fox M; Peng K; Lewin-Koh SC; Coleman D; Good J; Lowe J; Rahman A; Yang J; Jiang J; Quarmby V; Song A
J Immunol Methods; 2010 Oct; 362(1-2):101-11. PubMed ID: 20868690
[TBL] [Abstract][Full Text] [Related]
12. Development of a Generic Anti-PEG Antibody Assay Using BioScale's Acoustic Membrane MicroParticle Technology.
Dong H; Mora JR; Brockus C; Chilewski SD; Dodge R; Merrifield C; Dickerson WM; DeSilva B
AAPS J; 2015 Nov; 17(6):1511-6. PubMed ID: 26139446
[TBL] [Abstract][Full Text] [Related]
13. A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays.
Zoghbi J; Xu Y; Grabert R; Theobald V; Richards S
J Immunol Methods; 2015 Nov; 426():62-9. PubMed ID: 26255760
[TBL] [Abstract][Full Text] [Related]
14. Development of a Highly Specific Anti-drug Antibody Assay in Support of a Nanoparticle-based Therapeutic.
Wang Y; Smith JF; Araya MM; Liao KK; Gorovits B
AAPS J; 2020 Jun; 22(4):81. PubMed ID: 32488626
[TBL] [Abstract][Full Text] [Related]
15. Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA.
Chuang KH; Tzou SC; Cheng TC; Kao CH; Tseng WL; Shiea J; Liao KW; Wang YM; Chang YC; Huang BJ; Wu CJ; Chu PY; Roffler SR; Cheng TL
Anal Chem; 2010 Mar; 82(6):2355-62. PubMed ID: 20178318
[TBL] [Abstract][Full Text] [Related]
16. Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies.
Su YC; Chen BM; Chuang KH; Cheng TL; Roffler SR
Bioconjug Chem; 2010 Jul; 21(7):1264-70. PubMed ID: 20536171
[TBL] [Abstract][Full Text] [Related]
17. Effect of double antigen bridging immunoassay format on antigen coating concentration dependence and implications for designing immunogenicity assays for monoclonal antibodies.
Bourdage JS; Lee TN; Taylor JM; Willey MB; Brandt JT; Konrad RJ
J Pharm Biomed Anal; 2005 Sep; 39(3-4):685-90. PubMed ID: 15927431
[TBL] [Abstract][Full Text] [Related]
18. Strategies to estimate and improve drug tolerance in anti-drug antibody assays.
Bütikofer L; Lemaillet G; Faust H
Bioanalysis; 2012 Aug; 4(16):1999-2012. PubMed ID: 22946916
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a novel immunogenicity assay to detect anti-drug and anti-PEG antibodies simultaneously with high sensitivity.
Bivi N; Swearingen CA; Shockley TE; Sloan JH; Pottanat TG; Carter QL; Hodsdon ME; Siegel RW; Konrad RJ
J Immunol Methods; 2020 Nov; 486():112856. PubMed ID: 32916164
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity screening assay development for a novel human-mouse chimeric anti-CD147 monoclonal antibody (Metuzumab).
Mi L; Li W; Li M; Chen T; Wang M; Sun L; Chen Z
J Immunol Methods; 2016 Jun; 433():38-43. PubMed ID: 26944771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
